Andreas I Papadakis
Overview
Explore the profile of Andreas I Papadakis including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
27
Citations
532
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Steinberg C, Gaudreault N, Papadakis A, Henry C, Champagne J, Philippon F, et al.
Europace
. 2023 Jun;
25(6).
PMID: 37314195
Aims: Risk stratification for sudden cardiac death in patients with Brugada syndrome remains a major challenge. Contemporary risk prediction models have only modest predictive value. The aim of this study...
2.
Alsaddah S, Papadakis A, Wong N, Palma L, Szlachtycz D, Marino T, et al.
Lung Cancer
. 2023 May;
181:107247.
PMID: 37209596
Background: Somatic epidermal growth factor receptor (EGFR) pathogenic variants have been identified and are routinely tested in the molecular diagnosis of non-small cell lung cancer (NSCLC) as they represent a...
3.
Stockley T, Lo B, Box A, Gomez Corredor A, DeCoteau J, Desmeules P, et al.
Curr Oncol
. 2023 May;
30(4):3989-3997.
PMID: 37185415
The detection of gene fusions by RNA-based next-generation sequencing (NGS) is an emerging method in clinical genetic laboratories for oncology biomarker testing to direct targeted therapy selections. A recent Canadian...
4.
Stockley T, Lo B, Box A, Gomez Corredor A, DeCoteau J, Desmeules P, et al.
J Mol Diagn
. 2022 Dec;
25(3):168-174.
PMID: 36586421
The Canadian NTRK (CANTRK) study is an interlaboratory comparison ring study to optimize testing for neurotrophic receptor tyrosine kinase (NTRK) fusions in Canadian laboratories. Sixteen diagnostic laboratories used next-generation sequencing...
5.
Agulnik J, Papadakis A, Pepe C, Sakr L, Small D, Wang H, et al.
Curr Oncol
. 2022 Feb;
29(2):1107-1116.
PMID: 35200593
Background: Recent studies have demonstrated the utility of cell-free tumor DNA (ctDNA) from plasma as an alternative source of genomic material for detection of sensitizing and resistance mutations in NSCLC....
6.
Oughton M, Brukner I, Eintracht S, Papadakis A, Spatz A, Resendes A
Diagnostics (Basel)
. 2021 Dec;
11(12).
PMID: 34943608
Respiratory screening assays lacking Sample Adequacy Controls (SAC) may result in inadequate sample quality and thus false negative results. The non-adequate samples might represent a significant proportion of the total...
7.
Li J, Forghani R, Bure L, Wojtkiewicz G, Wu Y, Iwamoto Y, et al.
FASEB J
. 2021 Dec;
36(1):e22092.
PMID: 34919761
Detection and accurate delineation of tumor is important for the management of head and neck squamous cell carcinoma (HNSCC) but is challenging with current imaging techniques. In this study, we...
8.
Brukner I, Resendes A, Eintracht S, Papadakis A, Oughton M
Diagnostics (Basel)
. 2021 Jul;
11(7).
PMID: 34206413
Sample Adequacy Control (SAC) has critical analytical, clinical and epidemiological value that increases confidence in a negative test result. The SAC is an integral qPCR assay control, which ensures that...
9.
Xue Y, Zhu X, Meehan B, Venneti S, Martinez D, Morin G, et al.
J Pathol
. 2020 Jun;
252(1):77-87.
PMID: 32558936
Atypical teratoid rhabdoid tumor (ATRT) is a fatal pediatric malignancy of the central neural system lacking effective treatment options. It belongs to the rhabdoid tumor family and is usually caused...
10.
Brukner I, Eintracht S, Papadakis A, Faucher D, Lamontagne B, Spatz A, et al.
J Infect Public Health
. 2020 Feb;
13(7):991-993.
PMID: 32037201
Quantitative PCR (qPCR) is a leading screening tool, permitting rapid detection of pathogens and the maintenance of effective infection control programs. Unfortunately, qPCR assays frequently do not incorporate Sample Adequacy...